XTENT, Inc. (XTNT) - Product Pipeline Analysis by GlobalData

VIEWS: 22 PAGES: 34

More Info
									                                            XTENT, Inc. (XTNT) - Product Pipeline Analysis

     Reference Code: GDME2610PD                                                                                            Publication Date: NOV 2010



     Company Snapshot                                                     Company Overview
     Key Information
                                                                          XTENT, Inc. (XTENT), a development stage medical device company is
     XTENT, Inc., Key Facts                                               engaged in the design and manufacture of customizable drug-eluting stent
                                                                          (DES) systems for the treatment of coronary artery disease. The
     Web Address                            www.xtentinc.com
                                                                          company's customizable DES systems help to enable the treatment of
     Number of Employees                    6                             single, multiple and long with one device. It has multiple studies underway
                                                                          to evaluate its Custom NX DES platform. The company’s stent systems,
     Industry                               Pharmaceuticals and
                                                                          include, the Custom NX 36 and the Custom NX 60 and in addition, its
                                            Healthcare-
                                                                          stents have drug coating of Biolimus A9, an anti-inflammatory drug, and
     Source:Primary / Secondary Research
     GlobalData
                                                                          PolyLactic Acid, a biodegradable polymer.



     XTENT, Inc. Pipeline Products

     XTENT, Inc. Key Pipeline Products by Equipment Type                  XTENT, Inc. Key Pipeline Products by Therapy Area

     Equipment Type                                      No of Products   Therapy Area                                          No of Products
     Interventional Cardiology                                  4         Coronary artery disease                                      3
     Peripheral Vascular Devices                                   1      Peripheral arterial disease                                   1
                                                                          Restenosis                                                    1
     Source: Primary / Secondary Research                                 Source: Primary / Secondary Research
     GlobalData                                                           GlobalData


     XTENT, Inc. Key Pipeline Products by Equipment Type




     Source: Primary / Secondary Research
     GlobalData




     XTENT, Inc. Key Pipeline Products by Development                     XTENT, Inc. Key Pipeline Products by Trial Phase
     Stage
     Developmental Stage                No of Products                    Trial Phase                                    No of Products
     Clinicals                                 4                          Phase IV                                               -
     Pre-Clinicals                                                        Phase III                                              1
                                               -
     Early development                                         1          Phase II                                               1
     Source: Primary / Secondary Research                                 Phase I                                                1
     GlobalData
     Note : (-) indicates 'Not Available'                                 Source: Primary / Secondary Research
                                                                          GlobalData
                                                                          Note : (-) indicates 'Not Available'




XTENT, Inc. (XTNT) - Product Pipeline Analysis                                                                                  Reference Code: GDME2610PD

Source : www.globalcompanyintelligence.com                                                                                                              Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 3
     List of Figures......................................................................................................................................................................................................................................................................... 4
     Key Facts ............................................................................................................................................................................................................................................................................... 5
     XTENT, Inc. - Major Products and Services .......................................................................................................................................................................................................................... 6
           XTENT, Inc. Pipeline Products by Equipment Type ........................................................................................................................................................................................................ 7
           XTENT, Inc. Pipeline Products by Development Stage................................................................................................................................................................................................... 9
           XTENT, Inc. Pipeline Products by Therapy Area .......................................................................................................................................................................................................... 11
           XTENT, Inc. Pipeline Products by Trial Phase .............................................................................................................................................................................................................. 13
           XTENT, Inc. Pipeline Products by Milestone Summary ................................................................................................................................................................................................ 15
           Custom Drug Eluting Balloon......................................................................................................................................................................................................................................... 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
           Custom NX 36 Drug eluting stent .................................................................................................................................................................................................................................. 17
                 Product Status......................................................................................................................................................................................................................................................... 17
                 Product Description ................................................................................................................................................................................................................................................. 17
                 Product Milestone ................................................................................................................................................................................................................................................... 18
                 Custom NX 36 Drug eluting stent Clinical Trial ....................................................................................................................................................................................................... 18
                 Product Patent Details ............................................................................................................................................................................................................................................ 20
           Custom NX 60 Drug Eluting Stent ................................................................................................................................................................................................................................. 22
                 Product Status......................................................................................................................................................................................................................................................... 22
                 Product Description ................................................................................................................................................................................................................................................. 22
                 Product Milestone ................................................................................................................................................................................................................................................... 23
                 Custom NX 60 Drug Eluting Stent Clinical Trial ...................................................................................................................................................................................................... 23
                 Product Patent Details ............................................................................................................................................................................................................................................ 24
           Custom NX Bioabsorbable Stent System ...................................................................................................................................................................................................................... 26
                 Product Status......................................................................................................................................................................................................................................................... 26
                 Product Description ................................................................................................................................................................................................................................................. 26
                 Product Patent Details ............................................................................................................................................................................................................................................ 27
           Custom NX Peripheral Stent.......................................................................................................................................................................................................................................... 27
                 Product Status......................................................................................................................................................................................................................................................... 27
                 Product Description ................................................................................................................................................................................................................................................. 27
                 Product Patent Details ............................................................................................................................................................................................................................................ 28
     XTENT, Inc. - Key Competitors............................................................................................................................................................................................................................................ 29
     XTENT, Inc. - Key Employees ............................................................................................................................................................................................................................................. 
								
To top